Bicycle Therapeutics (BCYC) Accumulated Depreciation & Amortization (2018 - 2026)

Bicycle Therapeutics (BCYC) has 9 years of Accumulated Depreciation & Amortization data on file, last reported at $1.1 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Depreciation & Amortization fell 31.25% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (down 31.25% YoY), and the FY2025 full-year result was $6.4 million, down 11.11% from the prior year.
• Accumulated Depreciation & Amortization for Q1 2026 stood at $1.1 million, down from $6.4 million in the prior quarter.
• Across five years, Accumulated Depreciation & Amortization topped out at $10.4 million in Q2 2023 and bottomed at $1.1 million in Q1 2026.
• The 5-year median for Accumulated Depreciation & Amortization is $4.9 million (2023), against an average of $4.7 million.
• The widest annual swing landed in 2023, when Accumulated Depreciation & Amortization soared 101.58%; it then plunged 80.59% in 2024.
• A 5-year view of Accumulated Depreciation & Amortization shows it stood at $3.7 million in 2022, then surged by 75.68% to $6.5 million in 2023, then rose by 10.77% to $7.2 million in 2024, then decreased by 11.11% to $6.4 million in 2025, then slumped by 82.81% to $1.1 million in 2026.
• The last three Accumulated Depreciation & Amortization figures came in at $1.1 million (Q1 2026), $6.4 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.

Peer Comparison